Legal issues associated with the current and future practice of anti-aging medicine

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 7, 2004, Pages 674-681

  Reisman, Neal R ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

AGING; FOOD AND DRUG ADMINISTRATION; LAW SUIT; LEGAL ASPECT; LEGAL LIABILITY; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; SAFETY;

AGED; FORECASTING; FRAUD; GERIATRICS; HUMANS; INSURANCE COVERAGE; MALPRACTICE; ORGANIZATIONS; PRESCRIPTIONS, DRUG; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 4043096887     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Olshansky SJ, Hayflick L, Carnes BA. No truth to the fountain of youth. Sci Am. 2002;June:92-95.
2. Olshansky SJ, Hayflick L, Carnes BA. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B1-B6.
3. International Longevity Center. Workshop Report. Is There an Antiaging Medicine? (Canyon Ranch Series). New York: ILC; 2001.
4. Butler RN, Fossel M, Harman SM, et al. Is there an anti-aging medicine? J Gerontol Biol Sci. 2002;57A:B333-B338.
5. de Grey A, Gavrilov L, Olshansky SJ, et al. Anti-aging: one term, two worlds. Science. 2002;296:655.
6. Koenders RR. Products Liability: Sufficiency of Evidence to Support Product Misuse Defense in Actions Concerning Cosmetics and Other Personal Care Products. 58 A.L.R. 4th 40 (1987).
7. Olshansky SJ, Hayflick L, Carnes BA, et al. Position Statement on Human Aging. Scientific American (June). J Gerontol Biol Sci. 2002;57A:B1-B6.
8. Olshansky SJ, Carnes B, Cassel C. The aging of the human species. Sci Am. 1993;April:46-52.
9. Olshansky SJ, Carnes BA. Prospects for extended survival: a critical review of the biological evidence. In: Caselli G, Lopez A, eds. Health and Mortality Among Elderly Populations. Oxford: Clarendon Press; 1996:39-58.
10. Restatement (Second) of Torts s 532.
11. Report to Chairman Special Committee on Aging, U.S. Senate. Health Products for Seniors, "Anti-Aging" Products, Pose Potential for Physical and Economic Harm. GAO-01-1129 "Anti-Aging" Health Products. Washington, DC: General Accounting Office; 2001.
12. Reisman N. Medico-legal risks of age management program. Age Management Symposium, New Orleans, 2003.
13. Reisman N, Rohrich R, eds. Liability Issues With Ultrasonic Assisted Lipoplasty; Ultrasonic Assisted Liposuction. City?: Publisher?; 1998.
14. Reisman N. Liability Crisis Panel. American Society of Plastic Surgeons Annual Meeting, San Antonio, 2002.
15. Gorney M. The Doctor's Company. Professional Liability Committee, American Society of Plastic Surgeons (ASPS). Napa, CA: ASPS; 2003.
16. FDA. (1990, April). Industry-Supported Scientific and Educational Activities, FDA Consumer Update: Quackery targets teens. 62 Fed. Reg. at 64,094.
17. McEwin v Allstate Texas Lloyds, 118 S.W. 3d 811 (Tex. App.- Amarillo 2003).
18. Parker v Solis, 277 S.W. 714 (Tex. Civ. App. 1925).
19. Marywood v Vela, 53 S.W. 3d 684, 2001 (Tex. 2001).
20. Tex. Bus. & Comm. Code Ann. §§ 17.42, §§17.46(b) (19), 17.50.
21. 5 U.S.C. § Sec. 45(a)(1).
22. 21 U.S.C. § 333 (e)(f), § 956 (a).
23. Greater Houston Transp. Co. v. Phillips, 801 S.W.2d. 523 (Tex. 1990).
24. Olshansky SJ, Carnes BA, Cassel C. In search of Methuselah: estimating the upper limits to human longevity. Science. 1990;250:634-640.
25. Wadman M. EU warns on growth-hormone cancer risk. Nature. 1999;399:8.
26. Abbott A. What price the Olympian ideal? Nature. 2000;407:124-127.
27. Easterly v HSP of Texas, Inc., 772 S.W.2d. 211 (Tex. App.-Dallas 1989).
28. Tex. Bus. & Comm. Code Ann. §§ 2.316.
29. Harlow NO. Applicability of Warranty of Fitness under UCC § 2-315 to Supplies or Equipment used in Performance of Service Contract, 47 A.L.R. 4th 238 (1986).
30. Singleton v LaCoure, 712 S.W.2d. 757 (Tex. App.-Houston (14 Dist.) 1986).
31. Womco, Inc. v Navistar Int'l. Corp., 84 S.W.3d. 272 (Tex. App.-Tyler 2002).
32. FDA Consumer Magazine. Investigators' Reports: Maker of Growth Hormone Feels Long Arm of Law. (1999, September-October).
33. Koenders RR. Products Liability: Liability of Manufacturer or Seller as Affected By Failure of Subsequent Party in Distribution Chain to Remedy or Warn Against Defect of Which He Knew. 45 A.L.R. 4th 777 (1986).
34. The FDA Modernization Act, 21 U.S.C. 301 et seq.
35. Restatement (Second) of Agency s 1.
36. St. Joseph Hospital v Wolff, 94 S.W.3d 513 (Tex. 2002).
37. Bhalli v Methodist Hosp., 896 S.W.2d. 207 (Tex. App.-Houston (1 Dist.) 1995).
38. Baptist Memorial Hosp. System v Sampson, 969 S.W.2d. 945 (Tex. 1998).
39. 3 Am. Jur. 2d Agency § § 1-8, § § 17-22.
40. Knapp v Eppright, 783 S.W.2d. 293 (Tex.App.Houston (14 Dist). 1989).
41. King v Fisher, 918 S.W.2d. 108 (Tex. App. Fort Worth 1996).
42. Lee v Dewbre, 362 S.W.2d. 900 (Tex. App.-Amarillo 1962).
43. The Federal Food, Drug, and Cosmetic Act, 21 USC § 321 (1938).
44. Nordenberg T. Investigators' Reports. Maker of growth hormone feels long arm of law. FDA Consumer Magazine. 1999;5.
45. Rohrich R, Kinkel J, Reisman N. Use of off-label and non-approved drugs and devices in plastic surgery. Plastic Reconstr Surg. 2003;112:241-243.
46. Staudt v Froedtert Mem'l Lutheran Hosp., 580 N.W.2d. 361, 363 (App.1998).
47. Ortho Pharmaceutical Corp. v Cosprophar, Inc., 32 F.3d. 690, 692 (2d.Cir. 1994).
48. Smith JR, Olshansky SJ. Editorial. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B291.
49. FDA Regulatory Procedures Manual. Chapter 9: Import Operations (Revised May 12, 1998).
50. Reisman N. Common Characteristics of Most Successful Practices, Panel Discussion, American Society of Plastic Surgeons (ASPS), Los Angeles; 2000.
51. Zitter JM. Validity and Construction of Products Liability Statute Precluding or Limiting Recovery Where Product Has Been Abroad or Modified After Leaving Hands of Manufacturer or Seller. 41 A.L.R. 4th 47 (1985).